Erectile Dysfunction: Causes & What Works in 2026
Contents · 8 sections
The real causesThe evidence-based optionsWhat's oversoldDon't skip the heart checkThe bottom line - and where to startFrequently asked questionsRelated readingReferencesErectile dysfunction: causes and what actually works
TL;DR
- An erection is a vascular event - ED can precede a cardiac event by years, so evaluation matters for your heart, not just your sex life.
- The causes are vascular, hormonal, neurological, psychological or medication-related - find the cause before reaching for the pill.
- PDE5 inhibitors are the proven first line - sildenafil, tadalafil (longest-acting), vardenafil and avanafil (fastest), now affordable as generics.
- New formats in 2026 - VYBRIQUE, the first sildenafil oral dissolving film, and Eroxon (MED3000), the first OTC topical gel.
- Shockwave, PRP/"P-shot" and stem-cell therapy have insufficient or limited evidence - heavily marketed, not mainstay treatments.
- New-onset ED, especially under ~50, is a reason to check blood pressure, lipids and blood sugar.
Educational content for adults, not medical advice. No doses or protocols appear. New-onset ED warrants medical evaluation, partly because of its cardiovascular significance.
Erectile dysfunction is one of the most treatable sexual-health problems - but the most important fact about it is the one the ad-driven sites skip: an erection is a vascular event, so ED is often an early warning sign of cardiovascular disease. That makes a proper evaluation worth it for your heart, not just your sex life. The causes are usually vascular, hormonal, neurological, psychological, or medication-related, and the evidence-based options are well established - PDE5 inhibitors first-line (now in new formats as of 2026), with several "emerging" therapies that are heavily marketed but thin on evidence. The right approach finds the cause before reaching for the pill. Here's the grounded picture.
The real causes
| Cause | Notes |
|---|---|
| Vascular (most common) | Same process as heart disease - ED can precede a cardiac event by years |
| Hormonal | Low testosterone, thyroid, prolactin |
| Neurological | Diabetes, nerve damage, post-surgery |
| Psychological | Performance anxiety, depression - often in younger men |
| Medications/lifestyle | Blood-pressure drugs, antidepressants, smoking, alcohol |
The diagnostic-first point matters: treating ED without asking why can mean missing a treatable vascular or hormonal problem - which is exactly why "sexual optimization" clinics in 2026 increasingly lead with a workup, not a prescription.
The evidence-based options
First-line - PDE5 inhibitors (the proven core): sildenafil (Viagra), tadalafil (Cialis, longest-acting), vardenafil, and avanafil (Stendra, fastest). New in 2026: VYBRIQUE, the first sildenafil oral dissolving film (water-free), and Eroxon (MED3000), the first OTC topical gel (works in ~10 minutes, no prescription) - more formats, same well-established mechanism. Generics make the core options affordable.
Treat the cause too: if testosterone is low, address it; if it's a medication, review it; if it's psychological, treat that - a blood-flow drug won't fix anxiety.
What's oversold
A 2026 urology review is blunt about the popular "alternatives": shockwave therapy, PRP/"P-shot" injections, and stem-cell therapy have insufficient or limited evidence and aren't mainstay treatments; supplements like yohimbine carry safety concerns. These are marketed aggressively and priced high - approach with skepticism and ask for the actual data before paying.
The enlargement market sits in the same category and is worth reading with the same eye: what the evidence supports is a short list, most of what is sold has no support, and some of it carries documented harm.
Don't skip the heart check
Because ED so often reflects vascular health, new-onset ED - especially in men under ~50 - is a reason to check blood pressure, lipids, and blood sugar. Treating the erection while ignoring the warning is the costly mistake. This is the strongest argument for a real evaluation over an anonymous pill order.
The bottom line - and where to start
ED is highly treatable - PDE5 inhibitors work for most, now in more convenient 2026 formats - but it's also a cardiovascular signal worth heeding. The smart path: find the cause (vascular, hormonal, neurological, psychological, or medication), treat that alongside the symptom, take the heart implications seriously, and skip the unproven, expensive "emerging" therapies. The best ED decision isn't the flashiest treatment - it's the one that starts with why.
Explore it with verified supply. Every Vivre Labs lot is independently tested and the certificate of analysis is published, so you know exactly what is in the vial.
Frequently asked questions
What's the best treatment for erectile dysfunction? For most men, PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) are the proven first-line - now also available as an oral film and an OTC gel in 2026. But the best result comes from also treating the underlying cause.
Is erectile dysfunction a sign of heart problems? Often, yes. An erection is a vascular event, so ED can be an early warning sign of cardiovascular disease - sometimes years ahead. New-onset ED is a reason to check blood pressure, cholesterol, and blood sugar.
Do shockwave therapy and the P-shot work for ED? The evidence is insufficient or limited, and they're not mainstay treatments - despite heavy marketing and high prices. Ask for the actual data before paying for them.
Related reading
- How to improve sexual performance · Performance anxiety · Sexual health solutions in 2026 · Does penis enlargement work?
- Part of The Complete Guide to Sexual Health & Hormonal Vitality
Educational content for adults, not medical advice. ED can signal cardiovascular disease and warrants evaluation; treatments are physician-directed (PDE5 inhibitors carry interactions, e.g. with nitrates). Claims for the Malaysian market are subject to MAB requirements.
References
- PDE5 inhibitors as first-line ED therapy; ED as a marker/predictor of cardiovascular disease. · FDA approvals 2026: sildenafil oral film (VYBRIQUE, IBSA); Eroxon (MED3000) OTC topical. · Magill J. Emerging Treatments for Erectile Dysfunction. Trends Urol Mens Health. 2026 (shockwave/PRP - insufficient evidence).
Educational content only. This article is not a prescription, a dose, or a treatment recommendation. Products are sold for research use only - suitability, dosing and monitoring are not set on this site.